JAK2 and Rare hereditary thrombophilia: For this reason, a thrombophilia study was carried out (including testing for the factor-V-Leiden mutation, the G20210A prothrombin gene mutation, the JAK 2 mutation, protein C and S deficiency, and antithrombin deficiency), which was negative in all patients.